Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: Results from a trial of intramuscular interferon β-1a

D. M. Miller, B. Weinstock-Guttman, D. Bourdette, X. You, P. Foulds, R. A. Rudick

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: Results from a trial of intramuscular interferon β-1a'. Together they form a unique fingerprint.

Medicine & Life Sciences